{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:55:18Z","timestamp":1792166118541,"version":"4.4.0"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","funder":[{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"crossref","award":["3485\/19"],"award-info":[{"award-number":["3485\/19"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"crossref","award":["3485\/19"],"award-info":[{"award-number":["3485\/19"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To evaluate the effects of immunosuppressive therapy on the development and progression of age-related macular degeneration (AMD) in patients with an immune-mediated inflammatory disease.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This is a retrospective cohort study. Data were obtained from TriNetX, a global database of electronic medical records. The analysis used the largest network in TriNetX, comprised of 171,583,261 patients from 18 countries. Kaplan\u2013Meier analysis was used to estimate the probability of predefined AMD subcategories between patients with immune-mediated inflammatory disease who were prescribed an immunosuppressants and patients who were not.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>After 1:1 propensity score matching, equal-sized cohorts of patients in each group were generated for predefined IMIDs. We found that AMD was more prevalent in patients who received an immunosuppressant for systemic lupus erythematosus, Crohn disease, rheumatoid arthritis, sarcoidosis, Sj\u00f6gren syndrome, giant cell arteritis, and all IMIDs combined.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>The use of immunosuppressants in patients with some IMIDs appears to be associated with an increased risk of AMD. Further research is warranted to fully understand the complex relationship between immunosuppressive therapy and AMD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000004531","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T17:00:10Z","timestamp":1747674010000},"page":"1721-1726","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["THE EFFECTS OF IMMUNOSUPPRESSIVE THERAPY FOR IMMUNE-MEDIATED INFLAMMATORY DISEASE ON THE RISK OF AGE-RELATED MACULAR DEGENERATION"],"prefix":"10.1097","volume":"45","author":[{"given":"Natan","family":"Lishinsky-Fischer","sequence":"first","affiliation":[{"name":"Ophthalmology Department, Hadassah Medical Center, Jerusalem, Israel."},{"name":"Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itay","family":"Chowers","sequence":"additional","affiliation":[{"name":"Ophthalmology Department, Hadassah Medical Center, Jerusalem, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0043-4354","authenticated-orcid":false,"given":"Jaime","family":"Levy","sequence":"additional","affiliation":[{"name":"Ophthalmology Department, Hadassah Medical Center, Jerusalem, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250819","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0140-6736(22)02609-5","article-title":"Age-related macular degeneration","volume":"401","author":"Guymer","year":"2023","journal-title":"Lancet"},{"key":"R2-20250819","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.3390\/cells12162092","article-title":"The role of inflammation in age-related macular degeneration\u2014therapeutic landscapes in geographic atrophy","volume":"12","author":"Borchert","year":"2023","journal-title":"Cells"},{"key":"R3-20250819","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ajo.2007.06.025","article-title":"Age-related macular degeneration and the immune response: implications for therapy","volume":"144","author":"Nussenblatt","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"R4-20250819","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00281-008-0112-9","article-title":"Immunopathological aspects of age-related macular degeneration","volume":"30","author":"Patel","year":"2008","journal-title":"Semin Immunopathol"},{"key":"R5-20250819","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/eye.2010.196","article-title":"The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment","volume":"25","author":"Wang","year":"2011","journal-title":"Eye"},{"key":"R6-20250819","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.oret.2024.01.026","article-title":"Propensity-matched analysis of the risk of age-related macular degeneration with systemic immune-mediated inflammatory disease","volume":"8","author":"Shukla","year":"2024","journal-title":"Ophthalmol Retina"},{"key":"R7-20250819","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1001\/jamaophthalmol.2024.2376","article-title":"Janus kinase inhibitor therapy and risk of age-related macular degeneration in autoimmune disease","volume":"142","author":"Hallak","year":"2024","journal-title":"JAMA Ophthalmol"},{"key":"R8-20250819","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/ng.3448","article-title":"A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants","volume":"48","author":"Fritsche","year":"2016","journal-title":"Nat Genet"},{"key":"R9-20250819","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.3390\/biomedicines12071479","article-title":"Genetic insights into age-related macular degeneration","volume":"12","author":"Bora","year":"2024","journal-title":"Biomedicines"},{"key":"R11-20250819","doi-asserted-by":"crossref","first-page":"e81208","DOI":"10.7554\/eLife.81208","article-title":"CCR1 mediates M\u00fcller cell activation and photoreceptor cell death in macular and retinal degeneration","volume":"12","author":"Elbaz-Hayoun","year":"2023","journal-title":"Elife"},{"key":"R12-20250819","doi-asserted-by":"crossref","first-page":"e0203492","DOI":"10.1371\/journal.pone.0203492","article-title":"Systemic immunosuppression and risk of age-related macular degeneration","volume":"13","author":"Sandhu","year":"2018","journal-title":"PLoS One"},{"key":"R13-20250819","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.3906\/sag-2001-36","article-title":"The effect of long-term systemic immunosuppressive drug use on druse formation: a new perspective to age-related macular degeneration","volume":"50","author":"Sever","year":"2020","journal-title":"Turk J Med Sci"},{"key":"R14-20250819","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1177\/1073858413516799","article-title":"Protective autoimmunity: a unifying model for the immune network involved in CNS repair","volume":"20","author":"Schwartz","year":"2014","journal-title":"Neuroscientist"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004531","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T15:00:27Z","timestamp":1755615627000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":13,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004531","relation":{},"ISSN":["0275-004X","1539-2864"],"issn-type":[{"value":"0275-004X","type":"print"},{"value":"1539-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]}}}